Home > Insider Trading > Filing (0001415889-24-009164)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1370053	Anaptysbio Inc	ANAB	Pharmaceutical Preparations (2834)	203828755

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1673528	Daniel Faga	C/O Anaptysbio, Inc. 10770 Wateridge Circle, Suite 210 San Diego CA 92121	Ceo	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2024-03-22	145,940	$22.78	752,087	No	4	S	Direct
Common Stock	Disposition	2024-03-25	3,000	$21.42	749,087	No	4	S	Direct
Common Stock	Disposition	2024-03-26	347,441	$21.60	401,646	No	4	F	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	F	Direct

Footnotes

Represents shares sold by the Reporting Person to cover a portion of the tax withholding obligations in connection with the vesting and settlement of RSUs. The sales were to satisfy tax withholding obligations to be funded by "sell to cover transactions" and do not represent discretionary transactions by the Reporting Person.
The Reporting Person did not sell or otherwise dispose of any of the shares with respect to the vesting of RSUs reported on this Form 4 for any reason other than to cover required taxes.
Represents shares withheld by the Issuer to satisfy a portion of the tax withholding obligation in connection with the vesting of RSUs and do not represent discretionary transactions by the Reporting Person. Following the transactions reflecting in this Form 4, no additional transactions are expected to satisfy the Reporting Person's tax withholding obligation.